We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


Current practice and research activity

We currently use a mixture of direct spreads, cytospins and SurePath® Liquid Based Cytology (LBC) technology in our sample preparation.

All samples are prepared in a Containment level 3 room with Class 1 microbiological safety cabinets. Our research activity includes:

  • Use of MCM2 antibody in the detection of bladder cancer. This is a project done in collaboration with Cytosystems Ltd
  • Use of LBC technology in next generation sequencing

Non-gynae cytology research 1

Non-gynae cytology research 2


(Last updated April 21st 2016)